Shiongi out-licenses COT-143 to AMR Centre - The Pharma Letter
Shiongi out-licenses COT-143 to AMR Centre The Pharma Letter
Japanese drugmaker Shionogi (TYO: 4507) has entered into an out-licensing agreement on COT-143, a humanized monoclonal antibody targeting the PcrV ...
Comments
Post a Comment